CurveBeam AI News and Activities

CurveBeam AI is a company listed under the stock ticker CVB (AU).

View the org chart displaying its 9 main executives

Most searched biographies at CurveBeam AI

• Greg Brown, Chief Executive Officer
• Ego Seeman, Medical Director, Endocrinology
• Arun Singh, Chief Operating Officer and Chief Technology Officer, ...

Popular executive movements at CurveBeam AI

• Patrick Fisher has joined the company as Independent Non-Executive Director  (posted on March 19 2026).
• Kate Robb, Non-Executive Director, has left the company  (posted on December 21 2025).

Create your alert
to follow the executive moves at CurveBeam AI.

CurveBeam AI has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by CurveBeam AI

• News & Insights - CurveBeam AI Investors

Social media about CurveBeam AI

• CurveBeam AI on Wikipedia, Google News & Yahoo Finance
• CurveBeam AI on LinkedIn, X (Twitter) & YouTube